Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$6 Mln
Revenue (TTM)
$0 Mln
Net Profit (TTM)
$0 Mln
ROE
-1.5 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
2.6
Industry P/E
--
EV/EBITDA
-3.5
Div. Yield
0 %
Debt to Equity
0
Book Value
$--
EPS
$-2
Face value
--
Shares outstanding
2,231,829
CFO
$-417.82 Mln
EBITDA
$-659.71 Mln
Net Profit
$-831.00 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Alaunos Therapeutics (TCRT)
| -9.3 | -8.2 | -9.3 | 35.6 | -68.6 | -64.8 | -44.9 |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Alaunos Therapeutics (TCRT)
| 69.6 | -81.6 | -89.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Alaunos Therapeutics (TCRT)
|
2.9 | 6.3 | 0.0 | -4.0 | -61,333.3 | -208.5 | -- | 2.6 |
| 61.0 | 8,072.9 | 1,091.0 | 202.3 | 31.6 | 31.3 | 36 | 14.2 | |
| 229.3 | 13,405.2 | 691.7 | -219.0 | -13.7 | 163.2 | -- | 14.6 | |
| 66.7 | 7,755.6 | 88.0 | -785.0 | -808.1 | 197.5 | -- | 60.3 | |
| 43.9 | 11,247.3 | 2,320.1 | 782.6 | 39.0 | 35.5 | 14.9 | 5.0 | |
| 93.8 | 11,306.9 | 982.0 | -416.3 | -42.1 | 348.4 | -- | 55.7 | |
| 546.9 | 11,592.5 | 958.4 | -288.3 | -27.8 | -42.5 | -- | 16.8 | |
| 498.3 | 13,063.9 | 2,530.2 | 451.1 | 21.3 | 70.2 | 30.1 | 28.0 | |
| 105.4 | 7,603.8 | 0.0 | -425.4 | -- | -36.7 | -- | 6.0 | |
| 310.4 | 7,699.1 | 0.0 | -303.3 | -- | -45.8 | -- | 8.8 |
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders. The company develops an oral obesity compound that addresses shortcomings of injectable GLP-1... receptor agonists, including preserving lean muscle mass. It also evaluates ALN1001 and related derivatives on lipid deposition and gene expression. In addition, the company develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is headquartered in Houston, Texas. Address: 2617 Bissonnet Street, Houston, TX, United States, 77005 Read more
Interim CEO & Director
Mr. Dale Curtis Hogue Jr.
Interim CEO & Director
Mr. Dale Curtis Hogue Jr.
Headquarters
Houston, TX
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Alaunos Therapeutics Inc (TCRT) is $2.93 (NASDAQ) as of 02-Apr-2026 16:00 EDT. Alaunos Therapeutics Inc (TCRT) has given a return of -68.58% in the last 3 years.
Since, TTM earnings of Alaunos Therapeutics Inc (TCRT) is negative, P/E ratio is not available.
The P/B ratio of Alaunos Therapeutics Inc (TCRT) is 2.56 times as on 31-Mar-2026, a 35 discount to its peers’ median range of 3.94 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
-0.81
|
1.85
|
|
2023
|
0.00
|
0.02
|
|
2022
|
-0.02
|
0.02
|
|
2021
|
-0.01
|
0.02
|
|
2020
|
-0.03
|
0.02
|
The 52-week high and low of Alaunos Therapeutics Inc (TCRT) are Rs 6.20 and Rs 1.67 as of 04-Apr-2026.
Alaunos Therapeutics Inc (TCRT) has a market capitalisation of $ 6 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Alaunos Therapeutics Inc (TCRT), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-0.02
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.